Evidence map›Paper›PMID 42049211›Full record

ArticleBritish journal of haematology2026

Altered cytoskeletal integrity underlies impaired platelet shape change and defective thrombus formation in ETV6-related thrombocytopenia.

Ivan P Tesakov, Julia-Jessica D Korobkin, Daria V Fedorova, Sofia V Galkina, Maria M Golomysova, Sergei I Obydennyi, Anastasia A Ignatova, Ekaterina-Iva A Adamanskaya, Eugenia V Yushkova, Anna V Pavlova and 6 more

Abstract read
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ivan P TesakovDepartment of Oncology, Hematology, Clinical Immunology, and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany.ORCID https://orcid.org/0000-0002-9366-3449
Julia-Jessica D KorobkinCenter for Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow, Russia.ORCID https://orcid.org/0000-0002-2762-5460
Daria V FedorovaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID https://orcid.org/0000-0003-4567-1871
Sofia V GalkinaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID https://orcid.org/0009-0006-6321-4489
Maria M GolomysovaCenter for Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow, Russia.
Sergei I ObydennyiDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID https://orcid.org/0000-0002-2930-8768
Anastasia A IgnatovaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID https://orcid.org/0000-0002-5217-3937
Ekaterina-Iva A AdamanskayaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID https://orcid.org/0009-0000-4828-4063
Eugenia V YushkovaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Anna V PavlovaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID https://orcid.org/0000-0002-3974-5662
Pavel A ZharkovDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID https://orcid.org/0000-0003-4384-6754
Igor I KireevA.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.ORCID https://orcid.org/0000-0001-9252-6808
Galina A NovichkovaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID https://orcid.org/0000-0002-2322-5734
Viktor G ZgodaDepartment of Proteomic Research and Mass Spectrometry, V.N. Orekhovich Institute of Biomedical Chemistry, Moscow, Russia.
Mikhail A PanteleevDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID https://orcid.org/0000-0002-8128-7757
Anastasia N SveshnikovaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.ORCID https://orcid.org/0000-0003-4720-7319

Funding

Russian Science Foundation 21-74-20087Russian Science Foundation 23-45-10039Russian Science Foundation 23-75-10120Russian Science Foundation 24-15-00387
6 · The paper itself

Abstract

ETV6-related thrombocytopenia (ETV6-RT) is an inherited platelet disorder caused by germline ETV6 variants. Despite recent progress, the mechanisms underlying platelet dysfunction in ETV6-RT remain unclear. We investigated 12 patients from six families using functional assays, electron microscopy, quantitative proteomics and cytoskeletal imaging. Most patients exhibited mild-to-moderate thrombocytopenia with variable paediatric bleeding symptoms (median International Society on Thrombosis and Haemostasis Bleeding Assessment Tool 3, range 1-9) but consistently mild bleeding in adulthood (median 0, range 0-1). Ex vivo thrombus formation was reduced independent of platelet count. Electron microscopy revealed defective platelet shape maintenance, characterized by spheroid morphology, reduced D

Indexed as

Blood PlateletsCytoskeletonProto-Oncogene Proteins c-etsRepressor ProteinsThrombocytopeniaThrombosisAdolescentAdultCell ShapeChildChild, PreschoolETS Translocation Variant 6 ProteinFemaleHumansMaleMiddle AgedETS Translocation Variant 6 ProteinProto-Oncogene Proteins c-etsRepressor Proteinsbone marrow failureETV6ETV6‐related thrombocytopeniainherited platelet disordersplatelet function assaysplatelet proteomicsthromboinflammation

Identifiers

PMID42049211
PMCPMC13267443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.